Cytokinetics, Incorporated · NASDAQ:CYTK
Blum Robert I sold 7,500 Cytokinetics, Incorporated shares (Form 4)
Traded Nov 16, 2026 · Filed Nov 18, 2026
On Nov 16, 2026, Blum Robert I (Director, President & CEO) sold 7,500 Cytokinetics, Incorporated shares at an average US$53.53 for US$401K under a trading plan, leaving 278,544 shares. Filed Nov 18, 2026 (Form 4).
- Sold
- 7,500 shares
- Price
- US$53.53 average (US$53.22 to US$55.21)
- Value
- US$401K
- Holding after
- 278,544 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | Option exercise | 7,500 | US$10.60 | 286,044 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 5,077 | US$53.22 | 280,967 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 2,223 | US$54.08 | 278,744 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 200 | US$55.21 | 278,544 | Direct |
Source
Download original · View original at SEC
Related
- Cytokinetics, Incorporated
- Blum Robert I
- Cytokinetics, Incorporated shareholders
- Form 4 · Blum Robert I · Nov 2, 2026
- Form 4 · Blum Robert I · Oct 13, 2026
- Form 4 · Blum Robert I · Sep 28, 2026
- Form 4 · Blum Robert I · Sep 15, 2026
- Form 4 · Blum Robert I · Aug 31, 2026
- Form 4 · Malik Fady Ibraham · Nov 18, 2026
- Form 4 · Hessekiel Jeffrey · Nov 18, 2026
- Schedule 13G/A · Wellington Management Group LLP · Nov 16, 2026
- Form 4 · Parshall B Lynne · Nov 12, 2026
- Schedule 13G · State Street Corp · Nov 10, 2026